Specifically remove LDL cholesterol and lipoprotein(a) with lipid apheresis
Atherosclerosis (hardening of the vessels) is caused by the interaction of various risk factors. The focus here is an excessive concentration of lipoproteins ("blood lipids") in the blood. These can penetrate the walls of the blood vessels and lead to deposition processes up to vascular occlusion. Patients with this lipid metabolism disorder often suffer from atherosclerosis at an early stage. The risk of suffering a heart attack or stroke is often greatly increased. Quality of life often also suffers with this disease.
Most lipid metabolism disorders are associated with an increased LDL cholesterol level. It is often not possible for people with familial hypercholesterolemia to reduce the significantly high LDL cholesterol level sufficiently despite appropriate diet or medicinal treatment.
For these patients, lipid apheresis (or LDL apheresis, lipoprotein apheresis) can be used to reduce the content of the LDL cholesterol: the blood is cleansed of the unwanted LDL cholesterol outside the body and then returned to the patient. Lipid apheresis is precisely controlled and continuously monitored by state-of-the-art medical device technology.
A further risk factor for the development of atherosclerosis is the so-called lipoprotein(a) - often abbreviated as "Lp(a)". Lipoprotein(a) is today known to be an independent risk factor for the development of coronary heart disease.
With Lipidfiltration, DIAMED offers a therapy method for the selective, safe and compatible removal of LDL cholesterol and lipoprotein(a) from the blood.
In principle, we recommend that you consult the doctor who is treating you.
You will find further information on the treatment of lipid metabolism disorders with lipid apheresis in our Information for Patients. For a better understanding of other technical terms, please also refer to our Glossary.
©2018 DIAMED Medizintechnik GmbH